Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic …

V Restivo, S Candiloro, M Daidone, R Norrito… - Autoimmunity …, 2022 - Elsevier
… condition can lead to cardiovascular disease events. The purpose … of cardiovascular risk
among patients with rheumatic diseases as … cardiovascular events in terms of relative risk (RR). …

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …

GC Drosos, D Vedder, E Houben, L Boekel… - … rheumatic diseases, 2022 - ard.bmj.com
… Patients with inflammatory rheumatic diseases have an increased risk of cardiovascular
disease,1 in comparison to the general population, which prompted the development (2010) …

[HTML][HTML] Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment

AM Kerola, S Rollefstad, AG Semb - European Cardiology Review, 2021 - ncbi.nlm.nih.gov
… for drugs that are used to treat rheumatic diseases and have gained interest as potential drugs
… Misperception of the cardiovascular risk in patients with rheumatoid arthritis. Int J Environ …

The role of neutrophils in rheumatic disease-associated vascular inflammation

L Wang, R Luqmani, IA Udalova - Nature Reviews Rheumatology, 2022 - nature.com
… atherosclerotic burden and thrombotic risk in a mouse … in rheumatic diseases or cardiovascular
conditions, the potential of inhibiting PAD4 to reduce the increased cardiovascular risk

Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis

DJ DeMizio, LB Geraldino-Pardilla - Rheumatology and therapy, 2020 - Springer
… and coordination of CV disease (CVD) risk management in … focus on disease activity control
to mitigate excess CV risk, … CV risk of non-biologic disease-modifying anti-rheumatic drugs (…

The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis

G Ozen, S Pedro, K Michaud - The Journal of rheumatology, 2021 - jrheum.org
… Patients were participants in FORWARD, the National Databank for Rheumatic Diseases
Comparative cardiovascular risk of abatacept and tumor necrosis factor inhibitors in patients …

Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis

AG Semb, E Ikdahl, G Wibetoe, C Crowson… - … Reviews Rheumatology, 2020 - nature.com
… Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease
(CVD). … Cardiovascular Risk Consortium for RA (ATACC-RA) derived two candidate CVD …

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study

E Nikiphorou, S de Lusignan, CD Mallen, K Khavandi… - Heart, 2020 - heart.bmj.com
… future cardiovascular risk when using a whole population derived cardiovascular risk calculator
(eg, … . Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev …

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the …

N Conrad, G Verbeke, G Molenberghs, L Goetschalckx… - The Lancet, 2022 - thelancet.com
… Importantly, the observed excess cardiovascular risk with autoimmune disease was not
explained by traditional cardiovascular risk factors, such as age, sex, socioeconomic status, …

The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis

GS Metsios, RH Moe, M Van Der Esch… - Rheumatology …, 2020 - Springer
Cardiovascular disease (CVD) morbidity and mortality is highly prevalent in patients with
rheumatoid arthritis (RA) with debilitating effects for the individual as well as significant …